
9/15/2026
Xenetic Biosciences and Santersus Agree to All-Stock Combination to Create Nasdaq-Listed NET Therapeutics Company
Xenetic Biosciences and Santersus AG have agreed to an all-stock combination that would create a Nasdaq-listed NET therapeutics company spanning inflammatory disease, transplantation and oncology.
0
5 min read